Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
Author(s) -
Anat Ben-Shlomo,
Herbert Schmid,
Kolja Wawrowsky,
Oxana Pichurin,
Erika Hubina,
Vera Chesnokova,
NingAi Liu,
Michael D. Culler,
Шломо Мелмед
Publication year - 2009
Publication title -
endocrine reviews
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.357
H-Index - 272
eISSN - 1945-7189
pISSN - 0163-769X
DOI - 10.1210/edrv.30.6.9993
Subject(s) - pasireotide , somatostatin receptor , somatostatin receptor 2 , somatostatin , endocrinology , medicine , corticotropic cell , acromegaly , octreotide , lanreotide , pituitary tumors , anterior pituitary , hormone , growth hormone
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom